134 related articles for article (PubMed ID: 34955382)
1. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland.
Johansson E; Kallionpää RA; Böckerman P; Peltonen S; Peltonen J
Genet Med; 2022 Apr; 24(4):870-879. PubMed ID: 34955382
[TBL] [Abstract][Full Text] [Related]
2. The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland.
Kallionpää RA; Johansson E; Böckerman P; Peltonen J; Peltonen S
Eur J Hum Genet; 2024 Jan; 32(1):83-90. PubMed ID: 37460655
[TBL] [Abstract][Full Text] [Related]
3. A rare disease and education: Neurofibromatosis type 1 decreases educational attainment.
Johansson E; Kallionpää RA; Böckerman P; Peltonen J; Peltonen S
Clin Genet; 2021 Apr; 99(4):529-539. PubMed ID: 33368180
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
5. Increased risk for dementia in neurofibromatosis type 1.
Kallionpää RA; Valtanen M; Auranen K; Uusitalo E; Rinne JO; Peltonen S; Peltonen J
Genet Med; 2021 Nov; 23(11):2219-2222. PubMed ID: 34257422
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.
Kurtelius A; Kallionpää RA; Huttunen J; Huttunen TJ; Helin K; Koivisto T; Frösen J; von Und Zu Fraunberg M; Peltonen S; Peltonen J; Jääskeläinen JE; Lindgren AE
PLoS One; 2017; 12(6):e0178711. PubMed ID: 28575128
[TBL] [Abstract][Full Text] [Related]
8. Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Loponen N; Ylä-Outinen H; Kallionpää RA; Valtanen M; Auranen K; Järveläinen H; Peltonen S; Peltonen J
Mol Genet Genomic Med; 2024 Jan; 12(1):e2346. PubMed ID: 38131619
[TBL] [Abstract][Full Text] [Related]
9. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
10. Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study.
Kenborg L; Frederiksen LE; Galanakis M; Doser K; Nielsen TT; Doherty MA; Hove H; Østergaard JR; Handrup MM; Ejerskov C; Mulvihill JJ; Winther JF
Orphanet J Rare Dis; 2023 Nov; 18(1):346. PubMed ID: 37932779
[TBL] [Abstract][Full Text] [Related]
11. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract][Full Text] [Related]
12. The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Timonen S; Peltonen J; Peltonen S
Am J Med Genet A; 2017 Oct; 173(10):2641-2648. PubMed ID: 28815922
[TBL] [Abstract][Full Text] [Related]
13. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
[TBL] [Abstract][Full Text] [Related]
14. Variation in Prevalence of Rare Heritable Traits - A Simulation Study - Illustrated by Neurofibromatosis Type 1.
Stark AE
Twin Res Hum Genet; 2019 Aug; 22(4):229-232. PubMed ID: 31342894
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcomes in women with neurofibromatosis 1: a Danish population-based cohort study.
Kenborg L; Boschini C; Bidstrup PE; Dalton SO; Doser K; Nielsen TT; Krøyer A; Johansen C; Frederiksen K; Sørensen SA; Hove H; Østergaard JR; Mulvihill JJ; Winther JF
J Med Genet; 2022 Mar; 59(3):237-242. PubMed ID: 33495305
[TBL] [Abstract][Full Text] [Related]
16. Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.
Doser K; Hove H; Østergaard JR; Bidstrup PE; Dalton SO; Handrup MM; Ejerskov C; Krøyer A; Doherty MA; Møllegaard Jepsen JR; Mulvihill JJ; Winther JF; Kenborg L
BMJ Open; 2022 Sep; 12(9):e065340. PubMed ID: 36127120
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland.
Poyhonen M; Kytölä S; Leisti J
J Med Genet; 2000 Aug; 37(8):632-6. PubMed ID: 10991696
[No Abstract] [Full Text] [Related]
18. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficiency of the
Kallionpää RA; Peltonen S; Leppävirta J; Pöyhönen M; Auranen K; Järveläinen H; Peltonen J
J Med Genet; 2021 Jun; 58(6):378-384. PubMed ID: 32571896
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis 1 and dental caries.
Visnapuu V; Pienihäkkinen K; Peltonen S; Happonen RP; Peltonen J
Clin Oral Investig; 2011 Feb; 15(1):119-21. PubMed ID: 19727860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
